NCT02356432View on ClinicalTrials.gov

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

UnknownOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2017

Conditions
Ischemic StrokeAtrial Fibrillation Symptomatic
Trial Locations (3)

216-8511

St. Marianna University School of Medicine Hospital, Kawasaki

252-0373

Kitasato University Hospital, Sagamihara

236-0004

Yokohama City University Hospital, Yokohama

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Tokai University

OTHER

NCT02356432 - Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW) | Biotech Hunter | Biotech Hunter